News Image

What's going on in today's session

By Mill Chart

Last update: Apr 26, 2024

Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top gainers and losers in today's session.

Today's top gainers

TickerChangeComment
ATXI6.0K%AVENUE THERAPEUTICS INC (NASDAQ:ATXI) experienced a significant 6.0K% increase, reaching $7.66 during Friday's session. In the last month the share price dropped with 23.33%.
ZVSA682.0%ZYVERSA THERAPEUTICS INC (NASDAQ:ZVSA) rose 682.0% to $4.77 during Friday's after hours session. In the last month the share price dropped with 21.87%.
BDRX59.72%BIODEXA PHARMACEUTICALS-ADR (NASDAQ:BDRX) experienced a significant 59.72% increase, reaching $1.15 during Friday's session. The stock is trading 62.05% lower than 3 months ago.
PEGY46.44%PINEAPPLE ENERGY INC (NASDAQ:PEGY) witnessed a notable 46.44% uptick in its shares, reaching $0.08 during Friday's session. The stock is trading 89.82% lower than 3 months ago.
FCUV37.61%FOCUS UNIVERSAL INC's (NASDAQ:FCUV) shares rose 37.61% to $0.39. Shareholders saw the stock price going 36.38% lower in the past month.
SAVAW35.44%CASSAVA SCIENCES INC-28's (NASDAQ:SAVAW) stock price displayed strong growth, advancing 35.44% and reaching $0.42 during Friday's session. The stock is trading 92.44% lower than a month ago.
SBFM35.01%Positive market sentiment drove SUNSHINE BIOPHARMA INC's (NASDAQ:SBFM) stock price up by 35.01% to $1.09 during Friday's session. The stock is trading 85.84% lower than a month ago.
BOF34.18%Investors witnessed a remarkable 34.18% rise in BRANCHOUT FOOD INC/OR's (NASDAQ:BOF) shares, which climbed to $2.63 during Friday's session. The stock is trading 70.43% higher than 3 months ago.
AGEN33.19%AGENUS INC's (NASDAQ:AGEN) shares soared 33.19% to $11.05 during Friday's session. In the last month the share price dropped with 25.41%.
CGEM31.64%In an impressive move, CULLINAN THERAPEUTICS INC's (NASDAQ:CGEM) shares recorded a 31.64% increase, closing at $25.34 during Friday's session. Shareholders saw the stock price going 47.28% higher in the past 3 months.

Our top gainers page will show you the full list.

Losers

TickerChangeComment
NUWE-42.04%NUWELLIS INC's (NASDAQ:NUWE) shares fell 42.04% to $0.17. In the last month the share price dropped with 26.61%.
EJH-29.61%Investors witnessed a 29.61% drop in E-HOME HOUSEHOLD SERVICE's (NASDAQ:EJH) stock price, which closed at $0.54 during Friday's session. Shareholders saw the stock price going 41.67% lower in the past month.
SGBX-27.4%SAFE & GREEN HOLDINGS CORP's (NASDAQ:SGBX) stock price is declining with 27.4% to a price of $0.16. A press release (Safe & Green Holdings Announces it Has Entered Into an Agreement to Produce Four Modular Electrical Distribution Centers as Part of a Multi-Unit Order for a Client Serving the Big Box Retailer Market) was released yesterday.
BACK-23.92%During Friday's session, IMAC HOLDINGS INC's (NASDAQ:BACK) shares took a tumble, falling 23.92% to $3.88. In the last month the stock gained 67.21%.
SAIA-21.51%SAIA INC's (NASDAQ:SAIA) stock price is declining with 21.51% to a price of $426.19. SAIA INC released earnings Yesterday. Earlier today the company had a press release: Saia Announces Upcoming Retirement of CFO Douglas Col.
AIRE-17.27%Investors witnessed a 17.27% decrease in REALPHA TECH CORP's (NASDAQ:AIRE) stock price, which closed at $1.15 during Friday's session. The stock is trading 94.0% lower than 6 months ago.
ACON-17.01%ACLARION INC (NASDAQ:ACON) encountered a 17.01% decrease in its shares, reaching $0.33 during Friday's session. In the last month the share price increased with 20.65%.
XFOR-16.88%X4 PHARMACEUTICALS INC (NASDAQ:XFOR) encountered a 16.88% decrease in its shares, reaching $0.94 during Friday's session. The stock is trading 45.84% higher than 3 months ago.
VWE-16.79%Investors witnessed a 16.79% decrease in VINTAGE WINE ESTATES INC's (NASDAQ:VWE) stock price, which closed at $0.2 during Friday's session. In the last month the share price dropped with 33.61%.
KNSL-16.22%There was a notable decline in KINSALE CAPITAL GROUP INC's (NYSE:KNSL) shares, as they dropped 16.22% to $379.58 during Friday's session. In the last 6 months the stock gained 32.15%.

For the full top loser list go to our top losers page.

Back

ZYVERSA THERAPEUTICS INC

NASDAQ:ZVSA (5/17/2024, 7:00:03 PM)

After market: 4.48 -0.01 (-0.16%)

4.4872

-0.37 (-7.67%)

ZVSA News

News Image2 days ago - InvestorPlaceZVSA Stock Earnings: ZyVersa Therapeutics Misses EPS for Q1 2024

ZVSA stock results show that ZyVersa Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.

News Image2 days ago - BusinessInsiderZVSA Stock Earnings: ZyVersa Therapeutics Misses EPS for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips ZyVersa Therapeutics (NASDAQ:ZVSA) just reported results for the first quarter ...

News Image3 days ago - ZyVersa TherapeuticsZyVersa Therapeutics Reports First Quarter, 2024 Financial Results and Provides Business Update
News Image3 days ago - ZyVersa TherapeuticsZyVersa Therapeutics Reports First Quarter, 2024 Financial Results and Provides Business Update

ZyVersa is on track to achieve key development milestones over the next 3 quarters....

News Image4 days ago - ZyVersa TherapeuticsZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in the 2024 BIO International Convention
News Image4 days ago - ZyVersa TherapeuticsZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in the 2024 BIO International Convention

To learn more about ZyVersa's Inflammasome ASC Inhibitor and Renal Pipelines, schedule a one-on-one meeting on 2024 BIO International Conference's Portal....

News Image19 days ago - ZyVersa TherapeuticsZyVersa Therapeutics Announces Publication Reinforcing the Rationale for Inhibiting ASC with IC 100 to Potentially Attenuate Cardiac Comorbidities in Patients with Alzheimer’s Disease
News Image19 days ago - ZyVersa TherapeuticsZyVersa Therapeutics Announces Publication Reinforcing the Rationale for Inhibiting ASC with IC 100 to Potentially Attenuate Cardiac Comorbidities in Patients with Alzheimer’s Disease

NLRP1 & pyrin govern inflammation in Alzheimer’s Disease, and release of inflammasome laden extracellular vesicles induces cardiovascular inflammation....

News Imagea month ago - ZyVersa TherapeuticsZyVersa Therapeutics Highlights Published Data Demonstrating NLRP3 Inflammasome Inhibition Has Potential to Decrease Atherosclerotic Lesions in Patients with Diabetes
News Imagea month ago - ZyVersa TherapeuticsZyVersa Therapeutics Highlights Published Data Demonstrating NLRP3 Inflammasome Inhibition Has Potential to Decrease Atherosclerotic Lesions in Patients with Diabetes

Inhibiting inflammasome pathways has potential to attenuate atherosclerosis in patients with diabetes, a leading cause of morbidity & mortality....

News Image2 months ago - ZyVersa TherapeuticsZyVersa Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
News Image2 months ago - ZyVersa TherapeuticsZyVersa Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

Key Highlights:

ZVSA Links
Follow us for more